The Effect of Message Framing on Blood Donation-Study 2

March 24, 2019 updated by: OUYANG Jian, Guangzhou Blood Center

Saving a Life or Preventing a Death: the Effect of Message Framing on Blood Donation Among Rh Negative Donors

Rh negative blood group is a rare blood group in China, as it only accounts for 0.3-0.4 percent of the Han population. Therefore, low inventory is often found in blood collection and supply agencies in many regions in China. In order to assess the effects of the gain-versus-loss framing message on blood donation among Rh negative donors, we designed two kinds of self-administered, standardized and structured questionnaires. In addition of the basic socio-demographic characteristics, one questionnaire includes the questions which survey the attitude of saving patients lives, and the other was to survey the attitude of preventing patients from death. The questionnaires were randomly sent to Rh negative blood donors.

Study Overview

Study Type

Interventional

Enrollment (Actual)

795

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Guangdong
      • Guangzhou, Guangdong, China, 510095
        • Guangzhou Blood Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 60 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Rh negative blood donors who have donated blood between 2016 and 2018.

Exclusion Criteria:

  • People who are Rh negative blood type but never have donated blood.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Gain-frame questionnaire
Questionnaire included a picture of a patient lying in bed entitled "Will you save his life?" Donors in this group will answer the questions about attitude of saving patients' lives.
Questionnaires focusing on the attitude of saving patients' lives were given to Rh negative blood donors in this group.
Experimental: Loss-frame questionnaire
Questionnaire included a picture of a patient lying in bed entitled "Will you prevent him from death?" Donors in this group will answer the questions about the attitude of preventing patients from death.
Questionnaires focusing on the attitude of preventing patients from death were given to Rh negative blood donors in this group.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The differences of attitude towards different massage framing
Time Frame: 1 day
After participants view the picture in their questionnaires, they would answer the questions about attitude of saving patients' lives or preventing patients from death.
1 day

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 15, 2019

Primary Completion (Actual)

March 21, 2019

Study Completion (Actual)

March 21, 2019

Study Registration Dates

First Submitted

November 11, 2018

First Submitted That Met QC Criteria

November 11, 2018

First Posted (Actual)

November 14, 2018

Study Record Updates

Last Update Posted (Actual)

March 26, 2019

Last Update Submitted That Met QC Criteria

March 24, 2019

Last Verified

March 1, 2019

More Information

Terms related to this study

Other Study ID Numbers

  • Message Framing effect 2

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Rh Negative Blood Donor

Clinical Trials on Gain-frame questionnaire

Subscribe